๐ŸŽ—๏ธ OncologyTablet

    Fludarabine Phosphate

    fludarabine phosphate

    Fludarabine Phosphate for Injection treats adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen.

    Form

    Tablet

    Uses

    1

    Side effects

    4

    Category

    Oncology

    01

    What is Fludarabine Phosphate used for?

    • Fludarabine Phosphate for Injection is indicated for the treatment of adult patients with B-cell chr
    02

    fludarabine phosphate side effects

    Common side effects of fludarabine phosphate include:

    Myelosuppression (neutropenia
    Thrombocytopenia
    Anemia)
    Fever
    CommonModerateLess common
    03

    fludarabine phosphate warnings & precautions

    • (See BOXED WARNINGS ) Dose Dependent Neurologic Toxicities There are clear dose-dependent toxic effects seen with Fludarabine Phosphate for Injection.
    • Dose levels approximately 4 times greater (96 mg/m 2 /day for 5 to 7 days) than that recommended for CLL (25 mg/m 2 /day for 5 days) were associated w
    • Symptoms appeared from 21 to 60 days following the last dose.

    Loading FDA dataโ€ฆ

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Fludarabine Phosphate in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.